EE200300515A - Arüülsulfoonamiidid kui viirusevastased ained - Google Patents

Arüülsulfoonamiidid kui viirusevastased ained

Info

Publication number
EE200300515A
EE200300515A EEP200300515A EEP200300515A EE200300515A EE 200300515 A EE200300515 A EE 200300515A EE P200300515 A EEP200300515 A EE P200300515A EE P200300515 A EEP200300515 A EE P200300515A EE 200300515 A EE200300515 A EE 200300515A
Authority
EE
Estonia
Prior art keywords
sup
antiviral agents
arylsulfonamides
substituents
processes
Prior art date
Application number
EEP200300515A
Other languages
English (en)
Estonian (et)
Inventor
Wunberg Tobias
Bender Wolfgang
Eckenberg Peter
Hallenberger Sabine
Henninger Kerstin
Keldenich J�Rg
Kern Armin
Raddatz Siegfried
Reefschl�ger J�rgen
Schmidt Gunter
Zimmermann Holger
Zumpe Franz
Radtke Martin
Original Assignee
Bayer Aktiengeshellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Aktiengeshellschaft filed Critical Bayer Aktiengeshellschaft
Publication of EE200300515A publication Critical patent/EE200300515A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200300515A 2001-04-19 2002-04-08 Arüülsulfoonamiidid kui viirusevastased ained EE200300515A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (1)

Publication Number Publication Date
EE200300515A true EE200300515A (et) 2004-02-16

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300515A EE200300515A (et) 2001-04-19 2002-04-08 Arüülsulfoonamiidid kui viirusevastased ained

Country Status (20)

Country Link
US (1) US7115612B2 (xx)
EP (1) EP1383749B1 (xx)
JP (1) JP4480941B2 (xx)
CN (1) CN1516695A (xx)
AT (1) ATE308529T1 (xx)
BG (1) BG108272A (xx)
BR (1) BR0209054A (xx)
CA (1) CA2444123C (xx)
DE (1) DE50204780D1 (xx)
EE (1) EE200300515A (xx)
ES (1) ES2252455T3 (xx)
HU (1) HUP0303813A3 (xx)
IL (1) IL158324A0 (xx)
MX (1) MXPA03009548A (xx)
NO (1) NO20034667L (xx)
PL (1) PL363990A1 (xx)
RU (1) RU2003133750A (xx)
SK (1) SK12662003A3 (xx)
UY (1) UY27263A1 (xx)
WO (1) WO2002085869A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494164A1 (en) * 2002-08-23 2004-03-04 Rigel Pharmaceuticals, Inc. Pyridyl substituted heterocycles useful for treating or preventing hcv infection
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
SI3889142T1 (sl) 2003-04-11 2022-10-28 Ptc Therapeutics, Inc. Spojine 1,2,4-oksadiazol benzojske kisline in njihova uporaba za zatiranje nesmiselne ter zdravljenje bolezni
DE102006009928A1 (de) 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
SG170819A1 (en) 2006-03-30 2011-05-30 Ptc Therapeutics Inc Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
JP2010531850A (ja) * 2007-07-02 2010-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規化合物
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
BR112012033411A2 (pt) * 2010-06-28 2015-09-15 Bayer Ip Gmbh compostos heterocíclicos como pesticidas
EP2593434A1 (en) 2010-07-16 2013-05-22 Purdue Pharma LP Pyridine compounds as sodium channel blockers
US9206127B2 (en) 2012-03-16 2015-12-08 Purdue Pharm, L.P. Substituted pyridines as sodium channel blockers
EP2914591B1 (en) * 2012-11-03 2017-10-11 Boehringer Ingelheim International GmbH Inhibitors of cytomegalovirus
WO2014070979A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
US9714252B2 (en) 2012-12-20 2017-07-25 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
US9873677B2 (en) 2014-03-06 2018-01-23 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
WO2016128541A1 (en) * 2015-02-13 2016-08-18 Azienda Ospedaliera Universitaria Senese Human helicase ddx3 inhibitors as therapeutic agents
CN108348527A (zh) 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
AU765203B2 (en) * 1999-04-19 2003-09-11 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings

Also Published As

Publication number Publication date
SK12662003A3 (sk) 2004-04-06
UY27263A1 (es) 2002-11-29
JP2004531536A (ja) 2004-10-14
BG108272A (bg) 2004-10-29
CA2444123C (en) 2010-09-21
PL363990A1 (en) 2004-11-29
US7115612B2 (en) 2006-10-03
HUP0303813A3 (en) 2005-05-30
NO20034667L (no) 2003-12-12
EP1383749B1 (de) 2005-11-02
RU2003133750A (ru) 2005-05-10
IL158324A0 (en) 2004-05-12
HUP0303813A2 (hu) 2004-03-29
EP1383749A1 (de) 2004-01-28
JP4480941B2 (ja) 2010-06-16
ATE308529T1 (de) 2005-11-15
DE50204780D1 (de) 2005-12-08
ES2252455T3 (es) 2006-05-16
US20040176374A1 (en) 2004-09-09
NO20034667D0 (no) 2003-10-17
MXPA03009548A (es) 2004-05-24
CN1516695A (zh) 2004-07-28
BR0209054A (pt) 2004-04-20
CA2444123A1 (en) 2002-10-31
WO2002085869A1 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
EE200300515A (et) Arüülsulfoonamiidid kui viirusevastased ained
EA200500017A1 (ru) Новые соединения
BG106013A (en) New compounds and compositions as protease inhibitors
NO955047L (no) Sekundære aminer som antidiabetiske og antifedme-midler
NO20062644L (no) DPP-IV inhibitorer
EA200400648A1 (ru) N, n'-замещенные производные 1,3-диамино-2-гидроксипропана
DE60236600D1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
YU63703A (sh) 6-supstituisani pirido-pirimidini
TW200504067A (en) New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
DK1200418T3 (da) Nematodicide trifluorbutener
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
MXPA02011370A (es) Iminoazinas substituidas.
SE0302323D0 (sv) Novel compounds
MXPA03009750A (es) Compuestos quimicos.
SE0403171D0 (sv) New compounds
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
ATE368643T1 (de) Faktor xa benzamidin inhibitoren
MY141011A (en) Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
SE0101038D0 (sv) Novel compounds
ATE297903T1 (de) Substituierte phenyluracile
CA2356985A1 (en) 5ht1 antagonists for antidepressant therapy
MXPA04005988A (es) 3,4-dihidro-1h-isoquinolin-2-il-derivados.
HRP20010798B1 (en) Processes for preparing pesticidal intermediates

Legal Events

Date Code Title Description
HK1A Erratum in gazette